Drug alert: CDSCO flags 62 drug samples
In its latest drug alert, the apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO), has flagged 62 medicine batches for failing to qualify for a random drug sample test for the month of September.
These drug samples which are declared not of standard quality include Moxiflox-D Eye Drops, Viscoril AP, Caffeine Citrate Injection USP 60mg/3ml, Pyrazinamide-500 manufactured by Jackson Laboratories, Omeprazole Capsules IP 20 mg manufactured by Hindustan Antibiotics, Ascorbic Acid Tablets I.P. 500 mg. manufactured by ANG Lifesciences, Tobramycin Ophthalmic Solution USP 0.3% w/v manufactured by Zee Laboratories.
For more details, check out the link given below:
CDSCO Drug Alert: 62 Drug Samples Including Mankind Pharma's Rabekind 20 Flagged
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.